Clinical Trial Update: A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of the combination of Simeprevir and Daclatasvir in adults with chronic hepatitis C genotype 1b. The study comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Simeprevir (simeprevir)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Hepatitis C, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2017-01-20